pifithrin has been researched along with Idiopathic Parkinson Disease in 2 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karunakaran, S | 1 |
Saeed, U | 1 |
Mishra, M | 1 |
Valli, RK | 1 |
Joshi, SD | 1 |
Meka, DP | 1 |
Seth, P | 1 |
Ravindranath, V | 1 |
Chou, J | 1 |
Greig, NH | 1 |
Reiner, D | 1 |
Hoffer, BJ | 1 |
Wang, Y | 1 |
2 other studies available for pifithrin and Idiopathic Parkinson Disease
Article | Year |
---|---|
Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Benzothiazoles; Brain; | 2008 |
Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-α.
Topics: Animals; Behavior, Animal; Benzothiazoles; Brain Tissue Transplantation; Cell Count; Cell Survival; | 2011 |